RepligenvsThermo Fisher Scientific

RGEN and TMO stock compared: price, dividend, valuation and results, from SEC filings.

RGEN

Repligen Corporation

$162.25

Value $10.4B

-0.32%
RGEN's page

TMO

Thermo Fisher Scientific Inc

$689.15

Value $256B

-0.32%
TMO's page

Repligen (RGEN) has a market value of $10.4B and Thermo Fisher Scientific (TMO) $256B. Over the last year, with dividends, RGEN moved +6.5% and TMO +19.5%. Dividend yield: RGEN none, TMO 0.27%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    RGEN$10.4B

    TMO$256B

    TMO is 25 times RGEN

  • Revenue, 12 months

    RGEN$806M

    TMO$47.4B

    TMO is 59 times RGEN

  • Net income, 12 months

    RGEN-$12M

    TMO$7.1B

  • Operating margin

    RGEN2.3%

    TMO17.9%

    15.6 points apart

  • ROIC

    RGEN0.5%

    TMO8.2%

    7.7 points apart

  • P/E

    RGEN–

    TMO36.2

  • Dividend yield

    RGEN0.0%

    TMO0.3%

    0.3 points apart

  • 5-year return

    RGEN-39.7%

    TMO+9.0%

    48.7 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

RGEN-39.7%

TMO+9.0%

507510020222023202420252026
Returns by period
PeriodRGENWith dividendsTMOWith dividends
1 year since November 14, 2025+6.5%Price +6.5%+19.5%Price +19.1%
3 years since November 17, 2023+7.7%+2.5% a yearPrice +7.7%+49.2%+14.3% a yearPrice +47.8%
5 years since November 16, 2021-39.7%-9.6% a yearPrice -39.7%+9.0%+1.7% a yearPrice +7.4%
10 years since November 17, 2016+391.1%+17.3% a yearPrice +391.1%+376.2%+16.9% a yearPrice +362.9%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

RGENRepligenTMOThermo Fisher Scientific

Valuation

RGENTMO
Valuation
Price$162.25$689.15
Market value$10.4B$256B
Enterprise value (EV)$10.1B$291B
P/E–36.2
P/E, 5-year median–32.7
P/B5.04.7
EV/EBIT551.934.4
Free cash flow yield1.0%3.0%

Results and growth

RGENTMO
Results and growth
Revenue, 12 months$806M$47.4B
Net income, 12 months-$12M$7.1B
Free cash flow, 12 months$107M$7.6B
Earnings per share, 12 months-$0.21$18.96
Revenue growth, year on year16.4%3.9%
Revenue growth a year, past+15.0%over 5 years+6.7%over 5 years
EPS growth a year, past-5.0%over 5 years+2.1%over 5 years

Margins and returns on capital

RGENTMO
Margins and returns on capital
Gross margin53.5%–
Operating margin2.3%17.9%
Net margin-1.5%14.9%
ROIC0.5%8.2%
ROE-0.6%13.4%

Balance sheet

RGENTMO
Balance sheet
Cash$863M$6.1B
Total debt$692M$41.4B
Net debt / EBITDA-3.23.7
Interest cover0.8×5.5×

Dividends and buybacks

RGENTMO
Dividends and buybacks
Dividend yield–0.3%
Dividend per share, 12 months–$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield–1.2%
Shareholder yield–1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: RGEN or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Repligen or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($256B) is about 24.7 times Repligen ($10.4B), at today's prices.

How did RGEN and TMO stock do over the last 10 years?

Since November 17, 2016, RGEN's price moved +391.1% and TMO's +362.9%. With dividends: RGEN +391.1% (+17.3% a year), TMO +376.2% (+16.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, RGEN or TMO?

The dividend yield at today's price is none for Repligen and 0.27% for Thermo Fisher Scientific. Over the last twelve months they paid – and $1.84 per share.

Which has the higher profit margins, Repligen or Thermo Fisher Scientific?

Over the last twelve months, the net margin was -1.5% for Repligen and 14.9% for Thermo Fisher Scientific, and the operating margin 2.3% and 17.9%. Revenue was $806M and $47.4B.

Which is the better investment, Repligen or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.